0000899140-15-000901.txt : 20151223 0000899140-15-000901.hdr.sgml : 20151223 20151223142838 ACCESSION NUMBER: 0000899140-15-000901 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20151223 DATE AS OF CHANGE: 20151223 GROUP MEMBERS: MDRA GP LP GROUP MEMBERS: MONARCH GP LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCORPIO BULKERS INC. CENTRAL INDEX KEY: 0001587264 STANDARD INDUSTRIAL CLASSIFICATION: DEEP SEA FOREIGN TRANSPORTATION OF FREIGHT [4412] IRS NUMBER: 000000000 STATE OF INCORPORATION: 1T FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87971 FILM NUMBER: 151305358 BUSINESS ADDRESS: STREET 1: 9, BOULEVARD CHARLES III CITY: MC STATE: O9 ZIP: 98000 BUSINESS PHONE: (011)377 9798 5716 MAIL ADDRESS: STREET 1: 9, BOULEVARD CHARLES III CITY: MC STATE: O9 ZIP: 98000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Monarch Alternative Capital LP CENTRAL INDEX KEY: 0001281084 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 535 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-554-1700 MAIL ADDRESS: STREET 1: 535 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Quadrangle Debt Recovery Advisors LP DATE OF NAME CHANGE: 20070125 FORMER COMPANY: FORMER CONFORMED NAME: Quadrangle Debt Recovery Advisors LLC DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: QDRA LLC DATE OF NAME CHANGE: 20040223 SC 13D/A 1 s15943762a.htm AMENDMENT NO. 5

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*

Scorpio Bulkers Inc.
(Name of Issuer)
Common Stock, par value $0.01
(Title of Class of Securities)
Y7546A106
(CUSIP Number of Class of Securities)
Michael Kelly, Esq.
Monarch Alternative Capital LP
535 Madison Avenue
New York, NY 10022
Telephone: (212) 554-1700
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

Copies to:

Michael A. Schwartz, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY  10019-6099
(212) 728-8000

December 21, 2015
(Date of Event which Requires
Filing of this Schedule)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box:  ☒

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 240.13d-7 for other parties to whom copies are to be sent.

*  The remainder of this cover page shall be filled out for a reporting person's  initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


SCHEDULE 13D

 
CUSIP No.   Y7546A106 
 
 
 
Page 2 of 7 Pages
 

 
1
 
 
NAME OF REPORTING PERSON
 
Monarch Alternative Capital LP
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) ☐
(b) ☒
 
 
3
 
 
SEC USE ONLY
 
 
4
 
 
SOURCE OF FUNDS
N/A
 
 
5
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
☐ 
 
6
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
7
 
 
SOLE VOTING POWER
0
 
 
8
 
 
SHARED VOTING POWER
39,810,931*
 
 
9
 
 
SOLE DISPOSITIVE POWER
0
 
 
10
 
 
SHARED DISPOSITIVE POWER
39,810,931*
 
 
11
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
39,810,931*
 
12
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
☐ 
 
13
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.57%*
 
14
 
 
TYPE OF REPORTING PERSON*
PN, IA

*Reflects beneficial ownership as of December 22, 2015.
 

SCHEDULE 13D

 
CUSIP No.    Y7546A106 
 
 
 
Page 3 of 7 Pages
 

 
1
 
 
NAME OF REPORTING PERSON
 
MDRA GP LP
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) ☐
(b) ☒
 
 
3
 
 
SEC USE ONLY
 
 
4
 
 
SOURCE OF FUNDS
N/A
 
 
5
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
☐ 
 
6
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
 
7
 
 
SOLE VOTING POWER
0
 
 
8
 
 
SHARED VOTING POWER
39,810,931*
 
 
9
 
 
SOLE DISPOSITIVE POWER
0
 
 
10
 
 
SHARED DISPOSITIVE POWER
39,810,931*
 
 
11
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
39,810,931*
 
12
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
☐ 
 
13
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.57%*
 
14
 
 
TYPE OF REPORTING PERSON*
PN, HC

*Reflects beneficial ownership as of December 22, 2015.
 

SCHEDULE 13D

 
CUSIP No.    Y7546A106 
 
 
 
Page 4 of 7 Pages
 

 
1
 
 
NAME OF REPORTING PERSON
 
Monarch GP LLC
 
2
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) ☐
(b) ☒
 
 
3
 
 
SEC USE ONLY
 
 
4
 
 
SOURCE OF FUNDS
N/A
 
 
5
 
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
☐ 
 
6
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
 
7
 
 
SOLE VOTING POWER
0
 
 
8
 
 
SHARED VOTING POWER
39,810,931*
 
 
9
 
 
SOLE DISPOSITIVE POWER
0
 
 
10
 
 
SHARED DISPOSITIVE POWER
39,810,931*
 
 
11
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
39,810,931*
 
12
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
 
13
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.57%*
 
14
 
 
TYPE OF REPORTING PERSON*
OO, HC

*Reflects beneficial ownership as of December 22, 2015.
 

This Amendment No. 5 to Schedule 13D, dated December 23, 2015 (this “Amendment No. 5”), amends the Schedule 13D originally filed on June 10, 2015 (the “Original 13D”) by Monarch Debt Recovery Master Fund Ltd, Monarch Alternative Capital LP (“Monarch”), MDRA GP LP (“MDRA GP”) and Monarch GP LLC (“Monarch GP”), as amended by Amendment No. 1 to Schedule 13D filed on June 30, 2015, Amendment No. 2 to Schedule 13D filed on July 30, 2015, Amendment No. 3 to Schedule 13D filed on August 18, 2015 and Amendment No. 4 to Schedule 13D filed on October 28, 2015 (the Original 13D, as amended by such Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4 and this Amendment No. 5, the “Schedule 13D”).  This Amendment No. 5 is being filed on behalf of Monarch, MDRA GP and Monarch GP (collectively, the “Reporting Persons”).  This Amendment No. 5 relates to the common stock, par value $0.01 per share (the “Common Stock”), of Scorpio Bulkers Inc., a Marshall Islands corporation (the “Company”).  Monarch is the investment advisor to a variety of funds (any such funds, as applicable, collectively, the “Funds”).  The Reporting Persons are filing this Amendment No. 5 to amend Items 4, 5, 6 and 7 of the Schedule 13D as follows:

Item 4.                Purpose of the Transaction
Item 4 is hereby amended by adding thereto the following:
On December 21, 2015, Monarch, acting on behalf of the Funds, entered into an agreement with the Company (the “Agreement”), pursuant to which the Company will expand its board of directors (the “Board”), provide Monarch with consultation rights with respect to certain independent directors to be nominated to the Board, and amend its stockholder rights agreement.  Subject to the Company’s compliance with these obligations, Monarch has agreed to support the Board’s director nominees in 2016 and 2017.
The Agreement provides that the Company will expand the size of the Board to six (6) directors no later than January 31, 2016 and that it will appoint either Kurt M. Cellar or James B. Nish to fill the vacancy created by such newly-created directorship (such individual appointed by the Board, the “2016 Appointee”).  The Company has agreed that the 2016 Appointee will be appointed to the audit committee of the Board and that the Board will take all action necessary to continue the appointment of the 2016 Appointee to such committee for so long as he continues to meet the independence requirements necessary for membership.  In addition, pursuant to the Agreement, the 2016 Appointee will be included on the Board’s slate of director candidates for election at the Company’s 2016 annual meeting of shareholders (the “2016 Meeting”) for a term ending at the 2019 annual meeting of shareholders (the “2019 Meeting”).  Prior to or in connection with the Company’s 2017 annual meeting of shareholders (the “2017 Meeting”), the Company has agreed to expand the size of the Board to seven (7) directors and to appoint an individual who qualifies as an independent director to fill the vacancy created by such newly-created directorship (such individual appointed by the Board, the “2017 Appointee”).  The Agreement requires the Company to solicit proxies for the respective elections of the 2016 Appointee and the 2017 Appointee to the same extent as for the election or re-election of any other member of the slate.
The Company has also agreed that, until director nominees for the 2019 Meeting are certified by the inspector of such meeting, if the 2016 Appointee or his replacement is unable or unwilling to serve as a director of the Company at a time when Monarch beneficially owns at least 10% of the outstanding shares of Common Stock, the Board, prior to selecting a replacement, will provide to Monarch the same information about any replacement candidates as is provided to the Board, will allow Monarch to interview the candidates and will consult in good faith with Monarch on the desirability of appointing each candidate.  Additionally, prior to the 2017 Meeting, (i) if any individual is appointed to the Board, other than (A) as contemplated in the previous sentence or (B) to fill a vacancy created by the death or resignation of an incumbent director other than the 2016 Appointee, or (ii) if an individual who is not an incumbent director is included on the Board’s slate of director candidates for election to the Board
 

(including the slate for the 2017 Meeting), the Agreement provides that Monarch will have such consultation rights (subject to the same beneficial ownership requirement).
The Company has also agreed that, no later than January 15, 2016, it will amend its Stockholders Rights Agreement, dated as of June 18, 2015, by and between the Company and Computershare Trust Company, N.A., as Rights Agent (the “Rights Plan”), such that the definition of “Acquiring Person” thereunder will not include any person who, together with such person’s Affiliates and Associates, Beneficially Owns, or is the Beneficial Owner of, less than 20% of the outstanding shares of Common Stock (as all such capitalized terms are defined in the Rights Plan as of the date of the Agreement).  Additionally, the Company has agreed that it will not adopt or amend any rights plan or agreement (including the Rights Plan), or any other plan or agreement, having the effect of precluding or imposing economic costs or other consequences on a shareholder based on the fact that such shareholder Beneficially Owns, or is the Beneficial Owner of, less than 20% of the outstanding shares of Common Stock (as all such capitalized terms are defined in the Rights Plan as of the date of the Agreement).
Subject to the Company’s compliance with the provisions described in the previous three (3) paragraphs, Monarch has agreed not to nominate any person for election or to propose any business to be presented to the Company’s shareholders at the 2016 Meeting or the 2017 Meeting or to provide notice of any nomination or shareholder business, and it has agreed to vote all of the shares of Common Stock as to which it has voting power as of the record date of the applicable meeting in favor of the Board’s slate of director candidates for that meeting.
The foregoing description of the Agreement is qualified by reference to the Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Item 5.                Interest in Securities of the Issuer
Items 5(a) and 5(b) are hereby amended and restated in their entirety to read as follows:
(a)            Each of Monarch, MDRA GP and Monarch GP indirectly beneficially own 39,810,931 shares of Common Stock.  Such shares represent 11.57% of the 344,213,048 shares of Common Stock outstanding.  The percentages used herein and in the rest of this Amendment No. 5 are calculated based upon the 344,213,048 shares of Common Stock reported in the Company’s Form 6-K, dated as of November 24, 2015 (the “Form 6-K”), as outstanding as of November 16, 2015.  None of the individual Funds own a number of shares of Common Stock representing more than 5% of the outstanding shares of Common Stock.
(b)            Monarch, MDRA GP and Monarch GP share voting and dispositive power over 39,810,931 shares of Common Stock held directly by the Funds and by Monarch Shipping Holdings LLC (“Holdings”), a New York limited liability company of which the Funds are the only members, with each Fund and Holdings directly holding such shares, as applicable.
Item 5(c) is hereby amended by adding thereto the following:
On October 30, 2015, the Funds contributed to the capital of Holdings in proportion to their ownership of Holdings an aggregate of one hundred (100) shares of Common Stock.
Item 6.                Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Item 6 is hereby amended by adding thereto the following:
 

The information set forth in Item 4 is hereby incorporated herein by reference in response to Item 6.
Item 7.                Material to be filed as Exhibits
Item 7 is hereby amended by adding thereto the following:
Exhibit 10.1 – Agreement, dated December 21, 2015, by and between Scorpio Bulkers Inc. and Monarch Alternative Capital LP

[Signatures on following page]
 

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: December 23, 2015
MONARCH ALTERNATIVE CAPITAL LP
 
             By: MDRA GP LP, its General Partner
 
             By: Monarch GP LLC, its General Partner
   
   
 
By:  /s/ Michael Weinstock                                                
       Name:  Michael Weinstock
       Title:    Chief Executive Officer
   
   
Dated: December 23, 2015
MDRA GP LP
                By: Monarch GP LLC, its General Partner
   
 
By:  /s/ Michael Weinstock                                                   
       Name:  Michael Weinstock
       Title:    Member
   
   
   
Dated: December 23, 2015
MONARCH GP LLC
   
 
By:  /s/ Michael Weinstock                                                    
       Name:  Michael Weinstock
       Title:    Member
EX-10.1 2 s15943762b.htm AGREEMENT
Exhibit 10.1
AGREEMENT

This AGREEMENT (the “Agreement”) is made and entered into as of December 21, 2015, by and between Scorpio Bulkers Inc., a Marshall Islands corporation (the “Company”), and Monarch Alternative Capital LP, a Delaware limited partnership, acting on behalf of certain of its advisory clients (“Monarch”).


RECITALS
WHEREAS, Monarch is the investment manager of certain shareholders of the Company and, in such capacity, is the beneficial owner of certain shares of the common stock, par value $0.01 per share, of the Company (the “Common Stock”) owned directly by such shareholders; and
WHEREAS, Monarch has requested that the Company increase the size of its board of directors (the “Board”) and add two new independent directors to the Board; and
WHEREAS, the Board has been independently engaging in a process to expand the Board and add to the Board one or more new independent directors; and
WHEREAS, Monarch has identified to the Company two candidates to serve as directors of the Company that Monarch and the Company believe meet the criteria that the Board has independently established in its search process for one or more additional directors; and
WHEREAS, the Board has determined that it is in the best interests of the Company and its shareholders to add a new independent director to the Board in January 2016 and to add another independent director to the Board at or prior to the 2017 annual meeting of the Company’s shareholders (the “2017 Meeting”);
NOW, THEREFORE, in consideration of the premises, the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:


ARTICLE I.
AGREEMENTS
Section 1.1.  Addition of Directors to the Board.
(a)            No later than January 31, 2016, the Company shall take all action necessary (including the calling of a special meeting of the Board for any corporate action that may be required) to:
 

(x)            expand the size of the Board to six (6) directors so as to create a new directorship on the Board in accordance with Article I(a) of its Amended and Restated Articles of Incorporation (the “Amended Articles”), and
(y)            appoint either Kurt M. Cellar or James B. Nish, as the Board may choose, to fill the vacancy created by such newly-created directorship (such individual appointed by the Board, the “2016 Appointee”) in accordance with Article I(b) of the Amended Articles and to allocate the 2016 Appointee to the Board class to be elected at the Company’s 2016 annual meeting of shareholders (the “2016 Meeting”).
(b)            The Company agrees that it shall (i) appoint the 2016 Appointee to the audit committee of the Board upon the 2016 Appointee’s joining the Board and (ii) include the 2016 Appointee on the Board’s slate of director candidates for election at the 2016 Meeting and solicit proxies with respect to the 2016 Appointee’s election to the same extent as for the election or re-election of any other member of that slate.  The Company agrees that the Board shall take all action necessary to continue the appointment of the 2016 Appointee to the audit committee of the Board so long as the 2016 Appointee continues to meet the independence requirements necessary for membership on such committee.
(c)            Prior to or in connection with the 2017 Meeting, the Company shall take all action necessary to:
(x)            expand the size of the Board to seven (7) directors so as to create a new directorship on the Board in accordance with Article I(a) of  the Amended Articles, and
(y)            subject to Section 1.2 of this Agreement, appoint an individual who qualifies as an independent director to the Board class to be elected at the 2017 Meeting, or include an individual who qualifies as an independent director on the Board’s slate of director candidates for election at the 2017 Meeting and solicit proxies with respect to such individual’s election to the same extent as for the election or re-election of any other member of that slate, in either case to fill such newly-created directorship (such individual, the “2017 Appointee”).
Section 1.2.  Consultation Rights.
(a)            The Company agrees that, at any time prior to and including the date that director nominees for the 2019 annual meeting of the shareholders of the Company are certified by the inspector of such meeting, and provided that Monarch then beneficially owns at least 10% of the outstanding shares of Common Stock, if the 2016 Appointee (or any replacement for the 2016 Appointee) is unable or unwilling to serve as a director of the Company, the Board, prior to selecting an individual to replace such director, shall (i) provide to Monarch the same information about any replacement candidates as is provided to the members of the Board, (ii) shall permit Monarch the opportunity to interview such individuals and (iii) consult with Monarch in good faith as to the desirability of adding such individuals to the Board, and Monarch agrees to keep such information received from the Company about each replacement candidate confidential for a period of one year from receipt, except where (x) such information
 

becomes publicly available through no fault of Monarch, (y) Monarch receives such information from a source other than the Company that is not subject to an obligation of confidentiality with respect thereto, or (z) such information is required by law or legal process to be disclosed or is required or requested by a regulatory authority having jurisdiction over Monarch in the course of a routine examination or inquiry.
(b)            The Company agrees that, at any time prior to the 2017 Meeting, and provided that Monarch then beneficially owns at least 10% of the outstanding shares of Common Stock, if any individual is appointed to the Board other than as contemplated by Section 1.2(a) or to fill a vacancy created by the death or resignation of an incumbent director other than the 2016 Appointee, or if an individual who is not an incumbent director is included on the Board’s slate of director candidates for election to the Board (including, for the avoidance of doubt, the slate for the 2017 Meeting), in connection with and prior to such appointment or inclusion, the Board shall (i) provide to Monarch the same information about the candidates for such board seat as is provided to the members of the Board, (ii) shall permit Monarch the opportunity to interview such individuals and (iii) consult with Monarch in good faith as to the desirability of adding such individuals to the Board.
(c)            For purposes of this Section 1.2 and Section 1.3 of this Agreement, “beneficial ownership” and “beneficial owner” shall be determined in accordance with Section 13(d) of the United States Securities and Exchange Act of 1934, as amended, and Rules 13d-3 and 13d-5(b)(1) thereunder.  Nothing in this Section 1.2 shall derogate from the Board’s right to choose the individuals to be appointed to the Board or included on the Board’s slate of director candidates for election or re-election to the Board.
Section 1.3.  Rights Plan.  The Company agrees that, no later than January 15, 2016, the Company shall take all action necessary to amend that certain Stockholders Rights Agreement, dated as of June 18, 2015, by and between Scorpio Bulkers Inc. and Computershare Trust Company, N.A., as Rights Agent (the “Rights Plan”) such that the definition of “Acquiring Person” thereunder shall not include any Person who, together with such Person’s Affiliates and Associates, Beneficially Owns, or is the Beneficial Owner of, less than 20% of the Common Stock outstanding (as all such capitalized terms are defined in the Rights Plan as of the date hereof).  The Company agrees that it will not adopt or amend any rights plan or agreement (including the Rights Plan), or any other plan or agreement, having the effect of precluding or imposing economic costs or other consequences on a shareholder based on the fact that the shareholder Beneficially Owns, or is the Beneficial Owner of, any number of shares of Common Stock that is less than 20% of the Common Stock outstanding (as all such capitalized terms are defined in the Rights Plan as of the date hereof).
Section 1.4.  2016 Meeting.  Subject to the Company’s compliance with its obligations pursuant to Section 1.1(a), the first sentence of Section 1.1(b), and Section 1.3:
(a)            Monarch shall not nominate any person for election, or propose any business to be presented to the Company’s shareholders, at the 2016 Meeting or provide notice of any nomination or shareholder business at such meeting, and
 

(b)            Monarch shall vote all shares of Common Stock as to which it has voting power as of the record date for the 2016 Meeting in favor of the Board’s slate of director candidates for such meeting.
Section 1.5.  2017 Meeting.  Subject to the Company’s compliance with its obligations pursuant to Section 1.1(c), the second sentence of Section 1.1(b), Section 1.2(b), and Section 1.3:
(a)            Monarch shall not nominate any person for election, or propose any business to be presented to the Company’s shareholders, at the 2017 Meeting or provide notice of any nomination or shareholder business at such meeting, and
(b)            Monarch shall vote all shares of Common Stock as to which it has voting power as of the record date for the 2017 Meeting in favor of the Board’s slate of director candidates for such meeting.


ARTICLE II.
MISCELLANEOUS PROVISIONS
Section 2.1.  Representations and Warranties.
(a)            Each of the parties hereto represents and warrants to the other party that:
(i)             such party has all requisite authority and power to execute and deliver this Agreement and to consummate the transactions contemplated hereby,
(ii)            the execution and delivery of this Agreement and the consummation of the actions contemplated hereby have been duly and validly authorized by all required action on the part of such party and no other proceedings on the part of such party are necessary to authorize the execution and delivery of this Agreement and the actions contemplated hereby,
(iii)            the Agreement has been duly and validly executed and delivered by such party and constitutes the valid and binding obligation of such party enforceable against such party in accordance with its terms, and
(iv)            this Agreement will not result in a violation of any terms or provisions of any agreements to which such person is a party or by which such party may otherwise be bound or of any law, rule, license, regulation, judgment, order or decree governing or affecting such party.
(b)            The parties hereto acknowledge, warrant and represent that they have carefully read this Agreement, understand it, have consulted with and received the advice of counsel regarding this Agreement, agree with its terms, are duly authorized to execute it and freely, voluntarily and knowingly execute it.
Section 2.2.  General.
 

(a)            This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and thereof and supersedes all prior and contemplated arrangements and understandings with respect thereto.
(b)            This Agreement may be signed in counterparts, each of which shall constitute an original and all of which together shall constitute one and the same Agreement.
(c)            All notices and other communications required or permitted hereunder shall be effective upon receipt and shall be in writing and may be delivered in person, electronic mail, express delivery service or U.S. mail, in which event it may be mailed by first-class, certified or registered, postage prepaid, addressed to the party to be notified at the respective addresses set forth below, or at such other addresses which may hereinafter be designated in writing:
If to the Company:
Scorpio Bulkers Inc.
9, Boulevard Charles III
Monaco 98000
Attention: Luca Forgione
E-Mail: lforgione@scorpiogroup.net
with a copy to:
Seward & Kissel LLP
One Battery Park Plaza
New York, NY  10004
Attention: Edward Horton
E-mail: horton@sewkis.com
If to Monarch:
Monarch Alternative Capital LP
535 Madison Avenue, 26th Floor
New York, New York 10022
Attention: Roger Schmitz
E-Mail:  roger.schmitz@monarchlp.com
with a copy to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
Attention: Michael A. Schwartz, Esq.
E-Mail: mschwartz@willkie.com
(d)            Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid, but if any provision of this Agreement is held to be
 

invalid or unenforceable in any respect, such invalidity or unenforceability shall not render invalid or unenforceable any other provision of this Agreement.
(e)            It is hereby agreed and acknowledged that it will be impossible to measure in money the damages that would be suffered if the parties fail to comply with any of the obligations herein imposed on them and that in the event of any such failure, an aggrieved person will be irreparably damaged and will not have an adequate remedy at law.  Any such person, therefore, shall be entitled to injunctive relief, including specific performance, to enforce such obligations, without the posting of any bond, and, if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law.
(f)            Each party hereto shall do and perform or cause to be done and performed all such further acts and things and shall execute and deliver all such other agreements, certificates, instruments and documents as any other party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(g)            This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflicts of laws principles.  Each of the parties hereto hereby irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the courts of the United States District Court for the Southern District of New York or any court of competent jurisdiction in the State of New York, Borough of Manhattan, for any action, proceeding or investigation in any court or before any governmental authority arising out of or relating to this Agreement and the transactions contemplated hereby (and agrees not to commence any action, proceeding or investigation relating thereto except in such courts), and further agrees that service of any process, summons, notice or document by registered mail to its respective address set forth in this Agreement shall be effective service of process for any action, proceeding or investigation brought against it in any such court.  Each of the parties hereto hereby irrevocably and unconditionally waives any objection to the laying of venue of any action, proceeding or investigation arising out of this Agreement or the transactions contemplated hereby in the United States District Court for the Southern District of New York or any court of competent jurisdiction in the State of New York, Borough of Manhattan and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, proceeding or investigation brought in any such court has been brought in an inconvenient forum.
(h)            Any affiliate or advisory client of Monarch that holds shares of Common Stock shall be an intended third party beneficiary of this Agreement with power to enforce its terms.
 [Remainder of page intentionally left blank.]
 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the day and year first written above.

 
SCORPIO BULKERS INC.
 
   
 
By: /s/ Emanuele Lauro                                                
       Name:  Emanuele Lauro
       Title:    Chief Executive Officer
 
 
 
 
 
 

[Signature Page to Agreement]

 
MONARCH ALTERNATIVE CAPITAL LP,
 
on behalf of certain of its advisory clients
 
   
 
By: /s/ Michael Weinstock                                      
       Name:  Michael Weinstock
       Title:    Chief Executive Officer

 
 
 
 

[Signature Page to Agreement]